247 related articles for article (PubMed ID: 23982970)
1. Pathogenesis of graft-versus-host disease: innate immunity amplifying acute alloimmune responses.
Maeda Y
Int J Hematol; 2013 Sep; 98(3):293-9. PubMed ID: 23982970
[TBL] [Abstract][Full Text] [Related]
2. Toll-Like Receptor Stimulation by MicroRNAs in Acute Graft-vs.-Host Disease.
Zitzer NC; Garzon R; Ranganathan P
Front Immunol; 2018; 9():2561. PubMed ID: 30455702
[TBL] [Abstract][Full Text] [Related]
3. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
4. An adjuvant role of in situ dendritic cells (DCs) in linking innate and adaptive immunity.
Shimizu K; Fujii S
Front Biosci; 2008 May; 13():6193-201. PubMed ID: 18508653
[TBL] [Abstract][Full Text] [Related]
5. Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.
Faridi RM; Kemp TJ; Dharmani-Khan P; Lewis V; Tripathi G; Rajalingam R; Daly A; Berka N; Storek J; Masood Khan F
PLoS One; 2016; 11(6):e0158242. PubMed ID: 27341514
[TBL] [Abstract][Full Text] [Related]
6. Graft-versus-host disease.
Choi S; Reddy P
Panminerva Med; 2010 Jun; 52(2):111-24. PubMed ID: 20517195
[TBL] [Abstract][Full Text] [Related]
7. Reduced-Intensity Conditioning with Busulfan, Fludarabine, and Antithymocyte Globulin for Hematopoietic Cell Transplantation from Unrelated or Haploidentical Family Donors in Patients with Acute Myeloid Leukemia in Remission.
Lee KH; Lee JH; Lee JH; Kim DY; Park HS; Choi EJ; Ko SH; Seol M; Lee YS; Kang YA; Jeon M; Baek S; Kang YL; Kim SH; Yun SC; Kim H; Jo JC; Choi Y; Joo YD; Lim SN
Biol Blood Marrow Transplant; 2017 Sep; 23(9):1555-1566. PubMed ID: 28552421
[TBL] [Abstract][Full Text] [Related]
8. Anti-CD3 preconditioning separates GVL from GVHD via modulating host dendritic cell and donor T-cell migration in recipients conditioned with TBI.
Li N; Chen Y; He W; Yi T; Zhao D; Zhang C; Lin CL; Todorov I; Kandeel F; Forman S; Zeng D
Blood; 2009 Jan; 113(4):953-62. PubMed ID: 18922852
[TBL] [Abstract][Full Text] [Related]
9. Antigen-presenting cell-derived complement modulates graft-versus-host disease.
Kwan WH; Hashimoto D; Paz-Artal E; Ostrow K; Greter M; Raedler H; Medof ME; Merad M; Heeger PS
J Clin Invest; 2012 Jun; 122(6):2234-8. PubMed ID: 22585573
[TBL] [Abstract][Full Text] [Related]
10. Graft Cryopreservation Does Not Impact Overall Survival after Allogeneic Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis.
Hamadani M; Zhang MJ; Tang XY; Fei M; Brunstein C; Chhabra S; D'Souza A; Milano F; Phelan R; Saber W; Shaw BE; Weisdorf D; Devine SM; Horowitz MM
Biol Blood Marrow Transplant; 2020 Jul; 26(7):1312-1317. PubMed ID: 32283185
[TBL] [Abstract][Full Text] [Related]
11. Targeting the IL17 pathway for the prevention of graft-versus-host disease.
van der Waart AB; van der Velden WJ; Blijlevens NM; Dolstra H
Biol Blood Marrow Transplant; 2014 Jun; 20(6):752-9. PubMed ID: 24565991
[TBL] [Abstract][Full Text] [Related]
12. The role of danger signals and ectonucleotidases in acute graft-versus-host disease.
Apostolova P; Zeiser R
Hum Immunol; 2016 Nov; 77(11):1037-1047. PubMed ID: 26902992
[TBL] [Abstract][Full Text] [Related]
13. Tissue Damage Caused by Myeloablative, but Not Non-Myeloablative, Conditioning before Allogeneic Stem Cell Transplantation Results in Dermal Macrophage Recruitment without Active T-Cell Interaction.
van Balen P; van der Zouwen B; Kruisselbrink AB; Eefting M; Szuhai K; Jordanova ES; Falkenburg JHF; Jedema I
Front Immunol; 2018; 9():331. PubMed ID: 29535719
[TBL] [Abstract][Full Text] [Related]
14. Acute graft-vs-host disease: pathobiology and management.
Goker H; Haznedaroglu IC; Chao NJ
Exp Hematol; 2001 Mar; 29(3):259-77. PubMed ID: 11274753
[TBL] [Abstract][Full Text] [Related]
15. The IL-33/ST2 axis augments effector T-cell responses during acute GVHD.
Reichenbach DK; Schwarze V; Matta BM; Tkachev V; Lieberknecht E; Liu Q; Koehn BH; Pfeifer D; Taylor PA; Prinz G; Dierbach H; Stickel N; Beck Y; Warncke M; Junt T; Schmitt-Graeff A; Nakae S; Follo M; Wertheimer T; Schwab L; Devlin J; Watkins SC; Duyster J; Ferrara JL; Turnquist HR; Zeiser R; Blazar BR
Blood; 2015 May; 125(20):3183-92. PubMed ID: 25814531
[TBL] [Abstract][Full Text] [Related]
16. Programming of donor T cells using allogeneic δ-like ligand 4-positive dendritic cells to reduce GVHD in mice.
Mochizuki K; Meng L; Mochizuki I; Tong Q; He S; Liu Y; Purushe J; Fung H; Zaidi MR; Zhang Y; Reshef R; Blazar BR; Yagita H; Mineishi S; Zhang Y
Blood; 2016 Jun; 127(25):3270-80. PubMed ID: 27143255
[TBL] [Abstract][Full Text] [Related]
17. Graft rejection and hyperacute graft-versus-host disease in stem cell transplantation from non-inherited maternal-antigen-complementary HLA-mismatched siblings.
Okumura H; Yamaguchi M; Kotani T; Sugimori N; Sugimori C; Ozaki J; Kondo Y; Yamazaki H; Chuhjo T; Takami A; Ueda M; Ohtake S; Nakao S
Eur J Haematol; 2007 Feb; 78(2):157-60. PubMed ID: 17313562
[TBL] [Abstract][Full Text] [Related]
18. Partial T cell-depleted allogeneic stem cell transplantation following reduced-intensity conditioning creates a platform for immunotherapy with donor lymphocyte infusion and recipient dendritic cell vaccination in multiple myeloma.
Levenga H; Schaap N; Maas F; Esendam B; Fredrix H; Greupink-Draaisma A; de Witte T; Dolstra H; Raymakers R
Biol Blood Marrow Transplant; 2010 Mar; 16(3):320-32. PubMed ID: 19835972
[TBL] [Abstract][Full Text] [Related]
19. Delta-like ligand 4 identifies a previously uncharacterized population of inflammatory dendritic cells that plays important roles in eliciting allogeneic T cell responses in mice.
Mochizuki K; Xie F; He S; Tong Q; Liu Y; Mochizuki I; Guo Y; Kato K; Yagita H; Mineishi S; Zhang Y
J Immunol; 2013 Apr; 190(7):3772-82. PubMed ID: 23440416
[TBL] [Abstract][Full Text] [Related]
20. Etiology of GVHD: alloreactivity or impaired cellular adaptation?
Manjili MH; Toor AA
Immunol Invest; 2014; 43(8):851-7. PubMed ID: 25296238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
